Dante Labs, a global leader in genomics and precision medicine, announced today that it has partnered with the Renato Dulbecco Foundation to provide more personalized therapies for rare diseases, oncology and COVID-19. Protelica, the innovative US biotech company, has licensed its library of billions of pronectin nanoantibodies and a portfolio of 12 patents to the Renato Dulbecco Foundation. As part of the pharmaceutical research collaboration, the Renato Dulbecco Foundation will leverage the Dante Platform to identify nanoantibodies and their efficacy for a wide range of applications, including for the experimental treatment of COVID-19 and all of its variants resistant to traditional therapies. and orphan diseases. Further R&D activities will be outsourced to Twist Biosciences.

"Personalized medicine needs personalized data, and it is through partnerships like ours with the Renato Dulbecco Foundation that we can use the power of genomic information to treat disease and ultimately deliver better health outcomes for patients," stated Andrea Riposati, CEO of Dante Labs.

"I firmly believe that this collaboration will lead to the discovery of new pronectins that must be considered a new generation medicine and will pave the way for the treatment of still incurable diseases", said Prof. Giuseppe Nisticò, leader of the Renato Dulbecco Foundation and former member of the CHMP (Committee for Medicinal Products for Human Use) of the European Medicines Agency (EMA) and of the Management Board of EMA.

The collaboration received the enthusiastic approval of Dr. Roberto Crea, scientific director of the Renato Dulbecco Foundation, the famous scientist, pioneer of biotechnology and one of the first employees of Genentech.

The Renato Dulbecco Foundation has been selected to receive government funds of approximately 30 million dollars (approximately 27 million euros) and will have an employment impact for at least 100 people, including researchers, collaborators and employees. The institute is named after and celebrates Nobel Prize winner Renato Dulbecco, the famous Italian-American molecular biologist and virologist who received the 1975 Nobel Prize in Physiology and Medicine for his work on oncoviruses and cancer. He is considered the father of the decoding of the human genome.

About Dante Labs

Dante Labs is a global genomics data company that creates and markets a new class of transformative applications for health and longevity based on full genome sequencing and artificial intelligence. Our assets include one of the largest research consensus private genome databases, a proprietary software platform designed to harness the power of large-scale genomic data, and proprietary processes that enable an industrial approach to genomic sequencing.